# OnCo record eytan-stein (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/eytan-stein/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "eytan-stein" ;
  schema:name "Eytan M. Stein"@en ;
  schema:description "Led the enasidenib and revumenib trials that brought IDH2 and menin inhibitors to acute leukaemia."@en ;
  schema:url <https://onco.cc/people/eytan-stein/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Stein%20EM%5BAuthor%5D%20enasidenib%20OR%20revumenib> ;
  onco:tag "aml", "menin", "idh", "early-phase" ;
  schema:jobTitle "Chief, Leukemia Service, Memorial Sloan Kettering Cancer Center" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/> ;
  onco:targets <https://onco.cc/targets/idh/>, <https://onco.cc/targets/menin/> ;
  onco:drugs <https://onco.cc/drugs/revumenib/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:trials <https://onco.cc/trials/augment-101/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-augment-101-revumenib-menin-nature-2023/> ;
  onco:journals <https://onco.cc/journals/blood/> ;
  schema:affiliation <https://onco.cc/institutions/mskcc/> .